
Tracking of ME/CFS Cases in the Revised US ICD-10-CM
Since 2015, the 1-2.5 million Americans with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) have been effectively

Since 2015, the 1-2.5 million Americans with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) have been effectively

Today, AIM ImmunoTech, an immuno-pharma company focused on the research and development of therapeutics to

Long Haul Voices: Living with Long Covid and ME/CFS Solve M.E. is excited to announce the

David R. KotokThu Feb 17, 2022 This article was originally published by Cumberland Advisors and can

Second year of Solve/UCLA partnership September 2021–Solve M.E. is again partnering with the University of

Solve M.E.’s dedication to collaborative ME/CFS research is longstanding and includes initiatives such as the

In response to COVID-19, Solve M.E. co-founded the Long COVID Alliance (LCA), a network of

Solve ME partners with Action for ME on two-year research fellowship focused on identifying molecular

World’s largest ME/CFS data repository expands to Australia in initiative to open worldwide. April

We’re excited to announce that Solve M.E. has partnered with the University of California, Los Angeles

Advocacy Week Welcomes Partners from Long COVID and Rare Disease Communities The 5th Annual Solve

Today, Solve M.E. warmly welcomes 50 new partners in the fight to return millions